Subrata Chakravarty, Ph.D.
Chief Scientific Officer
Dr. Chakravarty has been awarded two Ph.D. degrees – one from Stony Brook University in Medicinal and Computational Chemistry and the second (M.S./Ph.D.) from the Indian Agricultural Research Institute in Soil Science and Agricultural Chemistry. The primary focus of his research career has been the discovery and exploration of new treatments for cancer and other chronic diseases. After 8 years of experience as a drug discovery scientist in the pharmaceutical industry, he realized that he could make a bigger impact with his work by shifting his attention to the field of non-toxic cancer therapies. During the past 12 years, Dr. Chakravarty has been the CEO of a startup health product and technology company, followed by his current role as the Chief Scientific Officer at the Hope4Cancer Treatment Centers.
As a valued member of the Hope4Cancer Executive Team, Dr. Chakravarty plays
an integral role in numerous areas including research and development, introduction of new treatments/therapeutic protocols, patient communication, and building Hope4Cancer’s scientific knowledge base in the field of integrative cancer medicine.
Dr. Chakravarty has been instrumental in the launch, enhancement and popularization of many of Hope4Cancer’s current treatment programs, the creation of patient support programs and information systems, and improvement in marketing campaigns.
As the holder of 3 issued patents, Dr. Chakravarty’s work includes 20 research papers published in peer-reviewed journals and book chapters. Additionally, he has written over 100 marketing-oriented books, manuals, blog articles, and other collateral marketing tools.